Published Date: 08 Dec 2023
Transfusion is not necessary when using iptacopan, as it outperforms C5 Inhibitors in maintaining hemoglobin levels.
Read Full NewsHere's some of what is coming soon to NeurologyLive® this week.
Allison B. Reiss, MD, associate professor of medicine at NYU Grossman Long Island School of Medicine discussed the often-overlooked early signs of early-onset Alzheimer disease.
Gefurulimab (Klygefa), a once-weekly, self-administered complement C5 inhibitor from Alexion and AstraZeneca, is now approved in the US for adults with AChR-antibody-positive generalized myasthenia gravis.
A new FDA filing seeks to expand cenobamate's epilepsy indication to primary generalized tonic-clonic seizures, based on positive phase 3 trial data.
The professor of neurology at UT Southwestern Medical Center discussed emerging trials, proposed changes to myelitis diagnostic criteria and nomenclature, and the unmet needs raised by patients at this year’s symposium.
A new global phase 2 trial, TARBELA-AD, will test RG6434, Roche's investigational oral NLRP3 inflammasome inhibitor, in adults with early symptomatic Alzheimer disease.
A pivotal phase 2/3 trial of Zhimeng Biopharma's CB03-154, an oral KCNQ2/3 potassium channel opener, has completed enrollment in amyotrophic lateral sclerosis.
1.
Gedatolisib Combo Approved for Advanced Breast Cancer
2.
Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer
3.
AI Framework Helps Classify Renal Tumors, Predict Outcomes
4.
For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.
5.
A study on lung cancer provides additional proof of the value of screening.
1.
Breakthroughs in Oncology: Advances in Immunotherapy, Radiation & Precision Diagnostics
2.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
3.
Best Clinical Practices in Hematology
4.
Vaccines that can help prevent cancer
5.
Demystifying the Mentzer Index: Understanding Its Importance in Inventory Management
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
How Hematologists Evaluate Persistent Blood Abnormalities
3.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
4.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
5.
How Advances in Cancer Research Are Improving Treatment Options
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation